Amonafide Maleate

N/A

Report date: 2022/11/25 16:34:12
NME

Base Information

Drug NameAmonafide Maleate
Drug Alias Name氨萘非特NafidimideAmonafidumAmonafideAmonafida +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsProstatic NeoplasmsBreast NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[24] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAntisoma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAntisoma Research LtdNational Cancer InstituteXanthus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsBreast NeoplasmsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG